(FTSV) Alert: Johnson Fistel Investigates Proposed Sale of Forty Seven, Inc.; Are Shareholders Getting a Fair Deal?

SAN DIEGO, March 2, 2020

On March 2, 2020, Forty Seven announced that it had signed a definitive merger agreement with Gilead Sciences. Under the terms of the deal, Forty Seven stockholders will receive $95.50 in cash.

The investigation concerns whether the Forty Seven board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Forty Seven shares of common stock.

If you are a shareholder of Forty Seven and believe the proposed buyout price is too low or you're interested in learning more about the investigation, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number.

Additionally, you can [Click here to join this action]. There is no cost or obligation to you.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit https://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com